fig1
Figure 1. A: Cumulative incidence of HBsAg seroclearance after liver transplantation; B: cumulative incidence of the development of detectable anti-HBs after liver transplantation; C: cumulative incidence of recurrent hepatocellular carcinoma after transplantation